Amgen SVP Sells ~$300k in AMGN Stock in Routine Transaction
AMGEN INC
Subscribe to track AMGN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Amgen SVP Sells ~$300k in AMGN Stock
Company: AMGEN INC (AMGN) Form: 4 | Filed: 2025-11-13 Significance: Low
Insider: Khosla Rachna Title: SVP, Business Development | Relationship: Officer
Transaction: • Type: Sell • Shares: 890 • Price: $336.24 • Value: $299,256 • Owned After: 7,082
Key Insight: An SVP sold a small portion of her holdings (~11%) in a transaction valued at approximately $300k. This is a routine, non-material sale for a mega-cap company like Amgen.
Market Context: The transaction value represents less than 0.0002% of Amgen's $174.28 billion market capitalization, indicating no significant market impact.
Comprehensive Analysis
SEC Filing Analysis: AMGEN INC (AMGN)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A senior executive at Amgen conducted a small, routine sale of company stock, likely for personal financial management.
- Market Impact: The transaction is negligible in the context of Amgen's massive market capitalization and is not expected to influence the stock's performance.
Company Information
| Field | Value |
|---|---|
| Company | AMGEN INC |
| Ticker Symbol | AMGN |
| CIK | 0000318154 |
| Industry | Biological Products |
Insider Information
| Field | Value |
|---|---|
| Name | Khosla Rachna |
| CIK | 0001881332 |
| Title/Position | SVP, Business Development |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-12 |
| Transaction Code | S (Open market or private sale) |
| Security Type | Common Stock |
| Shares Involved | 890 |
| Price Per Share | $336.2422 |
| Total Value | $299,255.56 |
| Shares Owned After | 7,082 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $299,255.56 |
| % of Market Cap | 0.00017% |
| Shares Transacted | 890 |
| % of Shares Outstanding | 0.000165% |
| Post-Transaction Ownership | 7,082 shares (0.0013% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: As a mega-cap company with a market capitalization of $174.28 billion, this transaction of approximately $300k is financially insignificant to the company and the market.
- Ownership Concentration: The insider's post-transaction holding of 7,082 shares represents a very small fraction (0.0013%) of the total shares outstanding, indicating low ownership concentration from this individual.
- Transaction Significance: The sale represents a minor portfolio adjustment for the insider and is immaterial from a corporate perspective, falling far below any thresholds for significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction's value and share count are too small relative to Amgen's market size and daily trading volume to have any discernible effect on the stock price.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is a negligible fraction of typical daily trading volume.
- Sentiment Indicator: Neutral. The market will likely view this as a routine, non-eventful insider transaction.
Additional Context
Transaction Notes
- Special Circumstances: The reported price is a weighted average. The shares were sold in multiple transactions at prices ranging from $336.2219 to $336.30.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
